The new paradigm: dementia in an era of treatments

Treatments mark a fundamental change for the field and overtime the experience and care of people with dementia. The first treatments mark a significant shift for the field. For the first time Alzheimer's disease is treatable. Even if the impact of treatments is limited and, at the moment, is available in only a few countries, this signals the direction of travel for the field. Over the years ahead there will be more treatments, for Alzheimer's and other forms of dementia, and to both manage symptoms and to modify the course of the disease. These will be easier and cheaper to deliver and bring greater benefits for patients and caregivers. The World Dementia Council is launching a new project exploring the impact and implications of new treatments and the early lessons from the roll out of these first treatments. The project begins with three virtual dialogues for global experts. The first dialogue will explore practical lessons from the delivery of treatments. As current treatments are approved in more countries, and we think about future treatments, in clinical and research settings, what early lessons can be drawn from the experience of delivering treatments to date? The second dialogue will explore lessons for advocacy movements. And a third dialogue will explore lessons for health systems. Further information about the project will be announced later in the year. Read more about the dialogues below. For further information about participating please contact info@worlddementiacouncil.com
  • Dialogue: 23 January 2025

    Chaired by Dr Maria Carrillo and Professor Philip Scheltens this virtual meeting will bring together international experts to explore early lessons from the delivery of treatments to patients who have a diagnosis of Alzheimer's disease. There will be opening remarks from Professor Gil Rabinovici, Professor Reisa Sperling and Professor Donna Wilcock with reflections from Dr Cath Mummey. This will be followed by an expert virtual roundtable expert dialogue. This events takes place on 23 January 2025. This is an invitation only meeting. 

    Read more
  • Dialogue: 27 February 2025

    Chaired by Dr Joanne Pike and George Vradenburg this virtual meeting will explore the lessons for advocacy movements from the roll out of the first treatments for Alzheimer's disease. The meeting will explore why treatments were adopted by some countries but not in others and how national and international advocacy organizations should respond. There will be opening remarks from three speakers followed by an expert virtual roundtable. The speakers for the event will be announced later in the year. This is an invitation only meeting. 

  • Dialogue: 3 March 2025

    Chaired by Professor Mark McCellan and Hilary Evans-Newton. There will be opening remarks from three speakers followed by an expert virtual roundtable. The speakers for the event will be announced later in the year. This is an invitation only meeting.